AR and breast carcinoma: Together, these lines of evidence suggest that intracrine androgen synthesis, higher androgen concentrations, and AR expression are strongly associated with a better prognosis, favorable therapeutic outcome, and a reduction in tumor in patients with AR-positive breast cancers.